Consistently, a meta-analysis of more than 170,000 pancreatic cancer patients suggested that statin use significantly reduces pancreatic cancer risk [167], although there was no correlation between increased HMGCR expression and shorter survival in pancreatic cancer patients [163]. This evidence concerns the gene HMGCR and pancreatic neoplasm.